Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Peptidomimetic‐based identification of FDA‐approved compounds inhibiting IRE1 activity

Journal article

Doultsinos D. et al, (2021), The FEBS Journal, 288, 945 - 960

Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges.

Journal article

Doultsinos D. and Mills IG., (2021), Cancers (Basel), 13

Pharmacological Targeting of IRE1 in Cancer

Journal article

Raymundo DP. et al, (2020), Trends in Cancer, 6, 1018 - 1030

The role of the androgen receptor as a driver and mitigator of cellular stress.

Journal article

Doultsinos D. and Mills I., (2020), J Mol Endocrinol, 65, R19 - R33